The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Assessment of health-related quality of life (HRQoL) in triple-class–exposed patients with relapsed or refractory multiple myeloma (RRMM) treated with linvoseltamab in the LINKER-MM1 trial.
 
James E. Hoffman
Stock and Other Ownership Interests - syndax
 
Naresh Bumma
Honoraria - Amgen; Janssen; Sanofi
Consulting or Advisory Role - Takeda
 
Joshua Ryan Richter
Honoraria - Adaptive Technologies; Bristol Myers Squibb Foundation; Janssen; Sanofi
Consulting or Advisory Role - Abbvie; Bristol Myers Squibb Foundation; Genentech; Janssen; Karyopharm Therapeutics; Pfizer; Regeneron; Sanofi; Takeda
Research Funding - Regeneron (Inst)
Travel, Accommodations, Expenses - Regeneron
 
Madhav V. Dhodapkar
Consulting or Advisory Role - Janssen Oncology; lava therapeutics; Roche/Genentech
 
Hans C. Lee
Consulting or Advisory Role - Abbvie; Allogene Therapeutics; Bristol Myers Squibb; Genentech; GlaxoSmithKline; Janssen Research & Development; Regeneron; Sanofi; Takeda
Research Funding - Amgen; Bristol-Myers Squibb/Celgene; GlaxoSmithKline; Janssen; Regeneron; Takeda
 
Attaya Suvannasankha
Consulting or Advisory Role - GlaxoSmithKline; Janssen Oncology
Research Funding - BMS (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Janssen Oncology (Inst); Regeneron (Inst)
Patents, Royalties, Other Intellectual Property - Novel bone anabolic agent in the treatment of cancer bone metastasis (Inst)
 
Jeffrey A. Zonder
Employment - Bristol-Myers Squibb
Consulting or Advisory Role - Alexion/Caelum; Bristol-Myers Squibb; Prothena; Regeneron
Research Funding - Bristol-Myers Squibb; Janssen
 
Joseph J. Maly
No Relationships to Disclose
 
Mansi R. Shah
Honoraria - MJH Life Sciences
Consulting or Advisory Role - Bristol-Myers Squibb; Janssen
Research Funding - Bristol-Myers Squibb; Janssen; Regeneron
 
Rachid C. Baz
Honoraria - Hikma Pharmaceuticals
Consulting or Advisory Role - BMS; Janssen; Pfizer; Sanofi
Research Funding - Abbvie (Inst); Arvinas (I); BMS (Inst); Daiichi Sankyo/Lilly (I); Janssen (Inst); Karyopharm Therapeutics (Inst); Marker Therapeutics (I); Pionyr (I); Quantum Leap Healthcare Collaborative (I); Regeneron (I); Seagen (I); Zymeworks (I)
Other Relationship - GlaxoSmithKline
 
Michelle DeVeaux
Employment - Regeneron
Stock and Other Ownership Interests - Regeneron
 
Cristina Ivanescu
Employment - IQVIA
Consulting or Advisory Role - Various pharma companies, such as BMS, Regeneron, Astellas, etc. (Inst)
 
Karen Rodriguez-Lorenc
Employment - Regeneron
Stock and Other Ownership Interests - Novartis; Regeneron
 
Glenn Scott Kroog
Employment - Regeneron
Stock and Other Ownership Interests - Regeneron
Research Funding - Regeneron
Travel, Accommodations, Expenses - Regeneron
 
Yariv J. Houvras
Employment - Regeneron
Stock and Other Ownership Interests - Regeneron
 
Timothy J Inocencio
Employment - Regeneron
Stock and Other Ownership Interests - Regeneron
 
Lei Chi
Employment - Regeneron
Stock and Other Ownership Interests - Regeneron
 
James Harnett
Employment - Regeneron
Stock and Other Ownership Interests - Pfizer; Regeneron
 
Qiufei Ma
Employment - Regeneron
Stock and Other Ownership Interests - Regeneron
 
Sundar Jagannath
Consulting or Advisory Role - Bristol-Myers Squibb; Caribou Biosciences; Janssen; Karyopharm Therapeutics; Legend Biotech; Regeneron; Sanofi; Takeda
Travel, Accommodations, Expenses - Brystol-Myers Squibb; Janssen Biotech